Penserra Capital Management LLC Vaxcyte, Inc. Transaction History

Penserra Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$19.32 - $26.45 $23,087 - $31,607	-1,195 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$20.26 - $26.97 $506 - $674	25 Added 2.14%	1,195 $30,000
Q2 2021 Aug 12, 2021	BUY	$16.45 - $24.06 $329 - $481	20 Added 1.74%	1,170 $26,000
Q1 2021 May 13, 2021	SELL	$18.66 - $29.16 $559 - $874	-30 Reduced 2.54%	1,150 $22,000
Q4 2020 Feb 12, 2021	BUY	$26.57 - $51.74 $31,352 - $61,053	1,180 New	1,180 $31,000

350

130M

539K

253K

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $4.43B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.